Biotech project manager civil penalty...
I promised earlier today that I would provide a copy of the "consent order" that was filed by the Minnesota Department of Commerce in relation to Geoff Griffin, contract project manager for the planned Elk Run biobusiness park in Pine Island, Minnesota for California-based developer Tower Investments, Inc.
Here's the file:
That way, you can read it and come to your own conclusions.
The Minnesota Department of Transportation has let contracts to begin construction of a new interchange at County Road 12 on U.S. 52 to serve the biobusiness park and Tower officials have said they will begin construction of the first biotech building no later than September 2, 2010.
It has become clear that construction will not begin unless companies have been found for the building, due to the current economic climate. So if construction begins, you can expect that Tower is certain of a near-100 percent occupancy. Stay tuned....
So far, I'm aware of three companies that want to have a presence at Elk Run:
• Exsulin (if its Phase 2 clinical trial results come out well later this year). It will produce a drug to trigger the bodies of long-term Type 1 diabetics to regenerate and protect insulin-producing cells. The clinical trial is underway at Mayo Clinic here in Rochester, Minnesota.
* Another company co-owned with Exsulin called Kinexum that helps biotech start-up companies get up and running.
• A third, unrelated company, that is interested in a second manufacturing site, but not for a couple of years yet.
By Jeff Hansel, member Association of Health Care Journalists
Health Reporter for the Post-Bulletin newspaper, 18 1st Ave. S.E. in Rochester, Minnesota 55904
Twitter Hansel's Pulse: @Jeff Hansel
Comments